Effect of MIST on Esophageal Sensitivity in HV (MIST)
Primary Purpose
Stress
Status
Recruiting
Phase
Not Applicable
Locations
Belgium
Study Type
Interventional
Intervention
Stress paradigm
Sham paradigm
Sponsored by
About this trial
This is an interventional other trial for Stress
Eligibility Criteria
Inclusion Criteria:
Aged between 18 to 65 years. All participants will receive and sign a copy of the informed consent before initiation of the study.
Exclusion Criteria:
- A history of any upper gastrointestinal (GI) symptoms, complaints or diseases;
- Prior history of esophageal or gastric surgery or endoscopic anti-reflux procedure;
- Psychiatric disorders;
- Concomitant use of other medication or treatments except for oral contraceptives;
- Use of medication altering GI motility;
- Pregnant or nursing women;
- History of drugs or alcohol abuse.
Sites / Locations
- TARGIDRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Sham Comparator
Arm Label
MIST-paradigm
Sham-paradigm
Arm Description
HV assigned in the MIST paradigm will receive psychosocial stress
HV assigned in the MIST paradigm will receive no psychosocial stress
Outcomes
Primary Outcome Measures
Esophageal mechanical sensitivity
Change in balloon distention
Esophageal chemical sensitivity
Change in time for reaching pain threshold
Secondary Outcome Measures
Cortisol levels
Change in cortisol levels
Full Information
NCT ID
NCT05427188
First Posted
October 20, 2021
Last Updated
June 16, 2022
Sponsor
Universitaire Ziekenhuizen KU Leuven
1. Study Identification
Unique Protocol Identification Number
NCT05427188
Brief Title
Effect of MIST on Esophageal Sensitivity in HV
Acronym
MIST
Official Title
Effect of Acute Psychosocial Stress on Esophageal Sensitivity in Healthy Volunteers
Study Type
Interventional
2. Study Status
Record Verification Date
June 2022
Overall Recruitment Status
Recruiting
Study Start Date
June 2022 (Anticipated)
Primary Completion Date
October 2022 (Anticipated)
Study Completion Date
October 2022 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Universitaire Ziekenhuizen KU Leuven
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
Effect of acute psychosocial stress on esophageal sensitivity in healthy volunteers.
Detailed Description
Gastro-esophageal reflux disease (GERD), defined as the presence of symptoms or lesions that can be attributed to the reflux of gastric contents into the esophagus, is an increasingly prevalent condition in Western societies. The most typical symptoms are heartburn and regurgitation, however GERD can also manifest itself through a variety of other esophageal and extra-esophageal symptoms (e.g. chronic cough).
GERD patients can be divided into different categories based on upper endoscopy and pH or impedance-pH (MII-pH) monitoring. In the absence of lesions (esophagitis) during upper endoscopy, a pH or MII-pH monitoring will be performed. A first subcategory are patients with true GERD, characterized by an abnormal acid exposure and a positive or negative symptom association. The second and third category are patients with reflux hypersensitivity (RHS) and functional heartburn (FH)characterized by normal acid exposure on the MII-pH monitoring and a positive and negative symptom reflux association, respectively.
The basis for symptom generation/perception in GERD patients is not yet completely understood, but different mechanisms have been proposed including esophageal hypersensitivity, in which psychosocial stress is considered as a potential factor. This was shown in a study where 64% of the participants with heartburn reported that psychological factors, such as life stress, aggravate their symptoms. Furthermore, Fass et al. observed that auditory stress exacerbated symptom perception during esophageal acid perfusion (6). Moreover, our group investigated the effect of intravenous corticotrophin releasing hormone (CRH) on esophageal in healthy volunteers and showed that CRH is able to increase esophageal sensitivity to mechanical distention. Nevertheless, these previously performed studies in patients have some limitations: no measurable increase in cortisol (hypothalamo-pituitary-adrenal (HPA)-axis was not affected in these studies) and patients with RHS and FH - in whom the effect of stress is hypothesized to be the most relevant - were not included.
To induce moderate psychologic stress in the current study, the Montreal Imaging Stress Task (MIST) will be used. During this protocol, participants receive mental arithmetic challenges, together with social evaluative threat components from the program and/or the investigator (sham condition: threat components from the program and/or the investigator are absent). This MIST protocol can be used when investigating the effects of perceiving and processing psychosocial stress in the human brain in functional imaging studies.
Therefore, we want to investigate the relation between sensitivity to different stimuli (esophageal sensitivity) and psychosocial stress in healthy volunteers and patients (True GERD, RHS and FH).
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Stress
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
Participant
Allocation
Randomized
Enrollment
24 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
MIST-paradigm
Arm Type
Experimental
Arm Description
HV assigned in the MIST paradigm will receive psychosocial stress
Arm Title
Sham-paradigm
Arm Type
Sham Comparator
Arm Description
HV assigned in the MIST paradigm will receive no psychosocial stress
Intervention Type
Behavioral
Intervention Name(s)
Stress paradigm
Intervention Description
HV will receive mental arithmetic challenges, together with social evaluative threat components from the program and/or the investigator
Intervention Type
Behavioral
Intervention Name(s)
Sham paradigm
Intervention Description
HV will receive mental arithmetic challenges where threat components from the program and/or the investigator are absent
Primary Outcome Measure Information:
Title
Esophageal mechanical sensitivity
Description
Change in balloon distention
Time Frame
Will be assessed at time point 180 minutes
Title
Esophageal chemical sensitivity
Description
Change in time for reaching pain threshold
Time Frame
We be assessed at time point 180 minutes
Secondary Outcome Measure Information:
Title
Cortisol levels
Description
Change in cortisol levels
Time Frame
every 15 minutes a saliva sample during 4.5 hours: at time points (in minutes) 0, 15, 30, 45, 60, 75, 90, 105, 120, 135, 150, 165, 180, 195, 210, 225, 240, 255, 27
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Aged between 18 to 65 years. All participants will receive and sign a copy of the informed consent before initiation of the study.
Exclusion Criteria:
A history of any upper gastrointestinal (GI) symptoms, complaints or diseases;
Prior history of esophageal or gastric surgery or endoscopic anti-reflux procedure;
Psychiatric disorders;
Concomitant use of other medication or treatments except for oral contraceptives;
Use of medication altering GI motility;
Pregnant or nursing women;
History of drugs or alcohol abuse.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Annelies Geeraerts
Phone
+321643385
Email
annelies.geeraerts@kuleuven.be
Facility Information:
Facility Name
TARGID
City
Leuven
State/Province
Vlaams-Brabant
Country
Belgium
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Annelies Geeraerts
Phone
01643385
Email
Annelies.Geeraerts@kuleuven.be
12. IPD Sharing Statement
Learn more about this trial
Effect of MIST on Esophageal Sensitivity in HV
We'll reach out to this number within 24 hrs